Automated Breast Ultrasound Systems (ABUS) - Global Strategic Business Report

The global market for Automated Breast Ultrasound Systems (ABUS) was estimated at US$852.1 Million in 2023, and is projected to reach US$2.0 Billion by 2030, growing at a CAGR of 13.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the Automated Breast Ultrasound Systems market is driven by several factors, including the rising global incidence of breast cancer, technological advancements in ultrasound imaging, and increasing awareness of the limitations of mammography in certain patient groups. As awareness of breast cancer screening increases, more women are seeking comprehensive screening solutions, particularly those who are identified as having dense breast tissue. Technological improvements in ABUS devices, such as enhanced imaging capabilities and the integration of AI, make these systems more appealing to healthcare providers by offering faster, more accurate readings and improving patient throughput. In addition, there is a growing demand for non-radiation-based diagnostic alternatives, which positions ABUS as a favorable option compared to traditional mammography, especially for younger women or those at higher risk of breast cancer. Regulatory bodies and healthcare organizations are also increasingly recommending supplementary ultrasound screening for women with dense breasts, further driving adoption of ABUS in clinical practices worldwide. These trends highlight the dynamic expansion of the ABUS market, fueled by both technological innovations and changing healthcare practices.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Automated Breast Volume Scanner segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of a 13.2%. The Automated Breast Ultrasound System segment is also set to grow at 13.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $232.1 Million in 2023, and China, forecasted to grow at an impressive 17.8% CAGR to reach $450.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Automated Breast Ultrasound Systems (ABUS) Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Automated Breast Ultrasound Systems (ABUS) Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Automated Breast Ultrasound Systems (ABUS) Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Canon Medical Systems Corporation, Delphinus Medical Technologies, Inc., Esaote SPA, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 86 Featured):

• Canon Medical Systems Corporation
• Delphinus Medical Technologies, Inc.
• Esaote SPA
• GE HealthCare
• Hologic, Inc
• Mindray DS USA, Inc.
• Planmed Oy
• QView Medical
• Samsung Healthcare
• Siemens Healthineers NV/SA
• SonoCiné, Inc.;